CClinicalTrials.gg
RecruitingNCT06042127Updated Dec 3, 2024

POEM-F for Achalasia International Study

An interventional study of POEM-F and Conventional POEM in Achalasia, sponsored by Chinese University of Hong Kong. Recruiting at 7 sites in 4 countries. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-12-03.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Dec 2023; still recruiting 2 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
81
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Per-oral endoscopic myotomy (POEM) has emerged as the endoscopic treatment of choice for achalasia, offering comparable symptom relief with laparoscopic Heller's cardiomyotomy. The main concern with POEM is the higher incidence of post-procedure gastroesophageal reflux disease (GERD), occurring in up to 50-60% of patients. In order to reduce the risk of GERD, endoscopic fundoplication has been developed as a novel procedure mimicking surgical anterior partial fundoplication that can be performed in the same session as POEM (POEM-F). Case series of POEM-F in patients with achalasia reported encouraging outcomes of low GERD rate of \~12% at 1 year. Prospective comparative data between POEM-F and conventional POEM on post-procedure GERD is current lacking. The investigators therefore designed an international multicenter prospective randomized study to investigate the efficacy of POEM-F. The investigators postulate that POEM-F could reduce the incidence of post-procedure GERD when compared with conventional POEM.

This is an international multicenter randomized controlled trial conducted between high volume expert centers from Hong Kong SAR, China, India and United States of America. Adult patients with manometry confirmed achalasia would be randomised to undergo POEM-F or POEM. The procedure would be performed by experts with vast experience in POEM. The primary outcome is the incidence of post-procedure GERD at 1 year, defined by the updated Lyon consensus. Secondary outcomes include technical and clinical success rates, adverse events, post-POEM endoscopic and manometry findings as well as patients' symptom scores.

Sample size calculation Based on existing pilot comparative data on POEM-F and POEM, it is estimated that 84 patients would be required to demonstrate a difference in post-procedure GERD of 47.6% to 18.2%, with 80% power and false positive rate of 0.05, accounting for 10% loss to follow-up.

Purpose and potential The current study proposal could demonstrate the superiority of POEM-F over POEM in reducing post-procedural GERD. It would also demonstrate the safety and reproducibility of the technique in expert centers across the globe. It could potentially replace conventional POEM as the preferred minimally invasive endoscopic treatment for achalasia.

Read the detailed description

Achalasia is the most common esophageal motility disorder worldwide, with an annual incidence of 1.6 per 100'000 individual and prevalence of 10 per 100'000 population. The incidence of achalasia has been dramatically rising over the past decade. A study conducted in Chicago suggested that over the 10 years from 2004 to 2014, the incidence and prevalence of achalasia were two- to threefold greater than estimates would have predicted. The likely explanation to the rise in incidence is an increased awareness of this condition and widespread availability of accurate diagnostic test with high resolution manometry. The cardinal features of achalasia include failed relaxation of lower esophageal sphincter and absent esophageal peristalsis. Owing to the benign nature of the disease, patients suffering from it would experience longstanding debilitating symptoms of dysphagia, chest pain, regurgitation, resulting in poor quality of life. In the past, laparoscopic Heller's cardiomyotomy with partial fundoplication and endoscopic pneumatic dilatation were considered as treatment options for achalasia.

In the past 10 years, per-oral endoscopic myotomy (POEM) has emerged as the incisionless minimally invasive endoscopic treatment of choice for achalasia. This Natural Orifice Transluminal Endoscopic Surgical (NOTES) technique involves mucosal incision and creation of a submucosal tunnel in the distal esophagus down to gastric cardia, followed by esophageal and gastric myotomy. Since the procedure was first reported by Inoue H, et al in 2010, it has seen worldwide acceptance as first-line therapy. POEM has been associated with excellent relief of dysphagia and achalasia-related symptoms with a low and acceptable adverse event rate of 0.5%. In a previous randomised controlled trial, POEM had a higher treatment success rate than pneumatic dilatation. When compared with laparoscopic Heller's cardiomyotomy, POEM was associated with at least similar treatment efficacy and a trend towards reduced short term adverse event. POEM could perform even better than surgical myotomy in patients with type III achalasia.

The main limitation of POEM is the incidence of gastroesophageal reflux disease (GERD) post-POEM. Kumbhari et al. looked at rates of GERD after POEM on patients who underwent subsequent objective pH testing. A total of 282 patients were included in this analysis from multiple centers in America, Asia, and Europe. About 58% of patients had objective evidence of abnormal acid exposure, with 23% showing evidence of esophagitis. More concerning, however, was that 60% of the patients with GERD were completely asymptomatic. This highlights an important issue at hand that many patients, either related to the propensity of GERD to be silent or the nature of achalasia to develop and insensate esophagus, do not report symptoms while showing high rates of GERD. POEM has been found to be consistently associated with higher rate of GERD than conventional Heller's cardiomyotomy or pneumatic dilatation across multiple studies.

Supported by evidence demonstrating the efficacy of partial fundoplication during Heller's operation, there has been a significant interest in performing fundoplication after POEM during the same session to prevent the development of post-POEM GERD. Inoue et al. pioneered the technique of POEM-F that mimics the surgical Dor (anterior partial fundoplication) procedure. In the pilot study, technical success was achieved in all 21 patients, and all but one had an intact fundoplication wrap on upper endoscopy at a 1-month follow-up. Four more studies conducted in Japan and India have reported good early outcomes with POEM-F (Technical success of 85-100%) for achalasia. No severe adverse event has been reported in these studies which reiterates the safety of this procedure. In the longest follow-up study on POEM-F, GERD diagnosed by an abnormal esophageal acid exposure was seen in 11.1% of the 21 cases at one-year follow-up: comparable (8.8%) to a large meta-analysis of 4871 Heller's cardiomyotomy with fundoplication procedures.

To date, no prospective multicenter randomised study has been conducted to compare the efficacy of POEM-F with conventional POEM in reducing post-procedure GERD. Therefore, in this study, the investigators aim to evaluate the of POEM-F in patients with achalasia through an international multicenter randomized controlled trial.

02

Conditions studied

  • Achalasia

Browse trials for

Keywords

  • POEM
  • Fundoplication
  • GERD
03

In context

Esophageal Achalasia

140 studies on the registry are indexed under Esophageal Achalasia; 44 are open to participants now.

This study's planned enrollment of 81 is above the median of 60 across 93 interventional studies indexed under Esophageal Achalasia.

Browse Esophageal Achalasia studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Adult patient (age ≥18 and ≤65 years-old) and with symptomatic achalasia type I or II.
  2. Capability of understanding and complying with the study requirements, including filling the Eckardt Score, GERD-HRQL and RSI questionnaire and signing the informed consent form.
  3. Patients with achalasia type I, II or III who are one of the following:

    • Treatment naïve, or
    • Failed prior through-the-scope balloon dilation, Savary or pneumatic dilation

Exclusion criteria

Exclusion criteria:

  1. Patients unable or unwilling to provide consent.
  2. Previous esophageal or gastric surgery.
  3. Prior achalasia treatment including Heller myotomy, POEM.
  4. Sigmoid achalasia, or significant esophageal dilatation >6cm in lower esophagus
  5. Disrupted mucosal integrity at the distal esophagus, eg. Ulcer, fibrotic scars etc
  6. Patients with large hiatal hernias (axial length > 2 cm and Hill grade >2).
  7. Patients with significant cardiorespiratory comorbidities which may limit their ability to undertake general anesthesia for the procedure, including ASA grade III or above.
  8. Patients with obesity (Body Mass Index (BMI) ≥ 30).
  9. Pregnant women or those planning pregnancy or breastfeeding women.
  10. Uncorrectable coagulopathy defined by international normalized ratio (INR) > 1.5 or platelet count \< 50000/µl.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
81 participants (estimated)

Study arms

  • Experimental
    Per-oral endoscopic myotomy with fundoplication

    The detail of the procedure has been reported in the literature. After completion of myotomy as per conventional anterior POEM, a serosal incision would be made at the level of the GE junction below the diaphragmatic crus. The peritoneal cavity would then be entered and the anterior gastric wall could be identified. A detachable endoloop would be introduced alongside the endoscope with the guidance of endoscopic clip. Three to four clips would be applied to the anterior gastric fundus while additional 3-4 clips would be applied to the edge of the submucosal tunnel, all anchoring to the endoloop. Upon tightening of the endoloop the anterior fundus would be approximated to the esophagogastric junction and thus completing the partial anterior fundoplication. Abdominal paracentesis to treat capnoperitoneum would be performed as required based on patient's clinical condition.

    Procedure: POEM-F

  • Active comparator
    Conventional POEM

    Conventional per-oral endoscopic myotomy An anterior POEM would be performed per usual manner described in the literature. The procedure would be performed under general anaesthesia by expert endoscopists with at least 50 case experience of conventional POEM and 5 cases experience of POEM-F. The requirement of POEM experience is based on a recent multicenter study of learning curve by Fujiyoshi Y, et al. The procedure would follow the current recommendations from expert panel in reducing GER, including avoidance of excessive gastric myotomy and preservation of the sling fibers are the gastric cardia. The length of the esophageal and gastric myotomy is standardized at 5cm and 2cm respectively

    Procedure: Conventional POEM

Interventions

  • ProcedurePOEM-F

    POEM-F would be performed as described in the arms section

  • ProcedureConventional POEM

    Anterior POEM performed as described in the arms section

06

What researchers measure

Primary outcomes

  1. Post-procedure rate of gastroesophageal reflux

    Defined by updated Lyon 2.0 consensus as fulfilling one or more of the criteria: 1. Endoscopic erosive esophagitis, LA grade B or above 2. Long segment Barrett's esophagus 3. Peptic esophageal stricture 4. 24-hour pH study with acid exposure time \>6% Both endoscopy and pH study to be performed with proton pump inhibitor stopped for 4 weeks

    Time frame: 1 year

Secondary outcomes

  1. Clinical success rate of procedure

    Post-treatment Eckhardt score \<=3

    Time frame: 1 year

  2. Adverse event of procedure

    frequency of severe adverse events with probable or definite attribution to the procedure based on the American Society of Gastrointestinal Endoscopy (ASGE) lexicon as well as Clavien Dindo classification

    Time frame: 30 day

  3. Technical success rate of procedure

    Completing all steps of the intended procedure successfully in the same session

    Time frame: 1 day

  4. Procedure time

    Procedure time of the intended procedure in minutes

    Time frame: 1 day

  5. Erosive esophagitis on post-procedure endoscopy

    The presence of erosive esophagitis as well as the grading on post-procedure endoscopy

    Time frame: 1 year

  6. Fundoplication wrap integrity on post-procedure endoscopy

    Endoscopic appearance of fundoplication wrap on retroflexion in the stomach. 1. Intact - wrap is completely visualised 2. Indistinct - wrap is visualised but appears to be loosened 3. Absent - the wrap is completely not visible

    Time frame: 1 year

  7. Distensibility index on EndoFLIP, premyotomy

    Distensibility index (mm2/mmHg) using EndoFLIP

    Time frame: During index procedure, before myotomy

  8. Distensibility index on EndoFLIP, post myotomy

    Distensibility index (mm2/mmHg) using EndoFLIP

    Time frame: During index procedure, after myotomy

  9. Distensibility index on EndoFLIP, post fundoplication

    Distensibility index (mm2/mmHg) using EndoFLIP

    Time frame: During index procedure, after fundoplication

  10. Distensibility index on EndoFLIP, on follow-up

    Distensibility index (mm2/mmHg) using EndoFLIP, at follow-up endoscopy

    Time frame: 1 year

  11. Maximum diameter on EndoFLIP, premyotomy

    Maximum diameter (mm) on EndoFLIP

    Time frame: During index procedure, before myotomy

  12. Maximum diameter on EndoFLIP, post-myotomy

    Maximum diameter (mm) on EndoFLIP

    Time frame: During index procedure, after myotomy

  13. Maximum diameter on EndoFLIP, post-fundoplication

    Maximum diameter (mm) on EndoFLIP

    Time frame: During index procedure, after fundoplication

  14. Maximum diameter on EndoFLIP, on follow-up

    Maximum diameter (mm) on EndoFLIP, at follow-up endoscopy

    Time frame: 1 year

  15. GERD-HRQL score

    Symptom and quality of life score relating to GERD The score ranged from 0-50 with higher score signifying more severe GERD symptom / worse quality of life

    Time frame: 1 month, 3 month, 6 month and 1 year

  16. GERD-RSI score

    Symptom and quality of life score relating to GERD The score ranged from 0-45 with higher score signifying more severe GERD symptom

    Time frame: 1 month, 3 month, 6 month and 1 year

  17. GERD-Q score

    Symptom and quality of life score relating to GERD The score is ranged from 0-18 with the higher score signifying more symptom of GERD

    Time frame: 1 month, 3 month, 6 month and 1 year

  18. Use of proton pump inhibitor post-procedure

    Number of participants who are on regular / as required / not on PPI

    Time frame: 1 month, 3 month, 6 month, and 1 year

07

Study locations

1 of 7 sites recruiting
  • Johns Hopkins Hospital
    Baltimore, Maryland 21287, United States
    • Mouen Khashab · Contact · mkhasha1@jhmi.edu
    • Farimah Fayyaz · Sub investigator
    • Mouen Khashab · Principal investigator
    Not yet recruiting
  • Nanfang Hospital, Southern Medical University
    Guangzhou, China
    Not yet recruiting
  • The Chinese University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting
  • Post Graduate Institute of Medical Education and Research
    Chandigarh, India
    Not yet recruiting
  • Asian Institute of Gastroenterology
    Hyderabad, India
    • Mohan Ramchandani · Contact · ramchandanimohan@gmail.com
    • Mohan Ramchandani · Principal investigator
    • Nabi Zaheer · Sub investigator
    Not yet recruiting
  • Baldota Institute of Digestive Sciences
    Mumbai, India
    • Amit Maydeo · Contact · amitmaydeo@gmail.com
    • Amit Maydeo · Principal investigator
    • Gaurav Patil · Sub investigator
    • Amat Nagesh · Sub investigator
    Not yet recruiting
  • Deenanath Mangeshkar Hospital & Research Center
    Pune, India
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06042127
Lead sponsor
Chinese University of Hong Kong
Collaborators
Deenanath Mangeshkar Hospital and Research Centre, Johns Hopkins University, Northwestern University Feinberg School of Medicine, Nanfang Hospital, Southern Medical University, Asian Institute of Gastroenterology, India, Post Graduate Institute of Medical Education and Research, Chandigarh
Responsible party
Hon Chi Yip (Assistant Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Sep 18, 2023
Start date
Dec 1, 2023
Primary completion
Oct 31, 2025 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Dec 3, 2024

Study contacts

Hon Chi Yip, FRCSEd
Contact
hcyip@surgery.cuhk.edu.hk
35052627
Hon Chi Yip, FRCSEd
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion